2nd Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$370,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative health care issues, including Alzheimers disease drug development; Drug Pricing; (HR _ / S. _) no bill number yet - Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA).

LobbyistCovered position, as disclosed
TRICIA BROOKS —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Medicare/Medicaid MMM

Part D Medicare Program, Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers therapies; H.R. 5376, Inflation Reduction Act (PL 117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy.

LobbyistCovered position, as disclosed
TRICIA BROOKS —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.